USFDA approves use of remdesivir to treat Covid-19 patients in hospitals

The approval of Veklury (remdesivir) was supported by the agency ’s analysis of data from three randomized, controlled clinical trials that included patients hospitalised with mild-to-severe COVID-19, the FDA said.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news